Tilmovet 250 mg/ml Concentrate for Oral Solution for pigs, chickens, turkeys and cattle (calves)

Land: Irland

Sprog: engelsk

Kilde: HPRA (Health Products Regulatory Authority)

Køb det nu

Hent Produktets egenskaber (SPC)
12-06-2017

Aktiv bestanddel:

Tilmicosin

Tilgængelig fra:

Huvepharma NV

ATC-kode:

QJ01FA91

INN (International Name):

Tilmicosin

Dosering:

250 milligram(s)/millilitre

Lægemiddelform:

Oral solution

Recept type:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutisk gruppe:

Cattle, Chickens, Pigs, Turkeys

Terapeutisk område:

tilmicosin

Terapeutiske indikationer:

Antibacterial

Autorisation status:

Authorised

Autorisation dato:

2008-10-24

Produktets egenskaber

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Tilmovet 250 mg/ml Concentrate for Oral Solution for pigs, chickens,
turkeys and cattle (calves)
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance
Tilmicosin: 250 mg per ml.
Excipients
For the full list of excipients: see section 6.1
3 PHARMACEUTICAL FORM
Concentrate for oral solution
Clear yellow to amber solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens (broilers and pullets), turkeys, pigs and cattle (calves).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs: For the treatment and prevention of respiratory infections
associated with_ Mycoplasma hyopneumoniae_,
_Pasteurella multocida and Actinobacillus pleuropneumoniae_ when the
disease has been diagnosed at the herd level.
Chickens:
For the treatment and prevention of respiratory infections in poultry
flocks associated with_ Mycoplasma gallisepticum_
_and Mycoplasma synoviae_ when the disease has been diagnosed at the
herd level.
Turkeys: For the treatment and prevention of respiratory infections in
turkey flocks associated with_ Mycoplasma_
_gallisepticum_ and_ Mycoplasma synoviae_ when the disease has been
diagnosed at the herd level.
Calves: For the treatment and prevention of respiratory infections
associated with_ Mannheimia haemolytica_,_ P._
_multocida, Mycoplasma bovis and M.dispar_ when the disease has been
diagnosed at the herd level.
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or in
cases of known resistance to tilmicosin. Do not use
in horses.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Tilmicosin should not be administered by injection to pigs. The
product contains disodium edetate.The uptake of
medicated water can be altered as a consequence of illness. If the
uptake is insufficient alternative treatment may be
required.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__
                                
                                Læs hele dokumentet
                                
                            

Søg underretninger relateret til dette produkt